Dampios, Bella Rae .

HRN: 27-59-92  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/22/2025
08/28/2025
IVT
40mg
Q24
Sepsis
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: